share_log

AppHarvest Analyst Ratings

AppHarvest Analyst Ratings

亞太醫藥分析師評級
Benzinga Analyst Ratings ·  2023/02/22 22:40
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
02/22/2023 120.09% Cowen & Co. $9 → $2 Maintains Outperform
12/02/2022 Oppenheimer Downgrades Outperform → Perform
02/25/2022 560.28% Oppenheimer $10 → $6 Maintains Outperform
08/26/2021 1000.47% Oppenheimer → $10 Initiates Coverage On → Outperform
06/16/2021 2651.18% Barclays → $25 Initiates Coverage On → Overweight
日期 上/下行 分析師公司 价格目標變更 評級變更 上一頁/目前評分
02/22/2023 120.09% 科恩 & 有限公司. 9 美元 → 2 美元 維護 跑贏大市
2022 年 12 月 2 日 奧本海默 降級 跑贏大市 → 執行
02/25/2022 560.28% 奧本海默 十美元 → 6 美元 維護 跑贏大市
2021 年 8 月 26 日 1000.47% 奧本海默 → 10 美元 啟動覆蓋範圍 → 跑贏大市
06/16/2021 2651.18% 巴克萊 → 25 美元 啟動覆蓋範圍 → 超重

What is the target price for AppHarvest (APPH)?

安全醫藥 (APPH) 的目標價格是多少?

The latest price target for AppHarvest (NASDAQ: APPH) was reported by Cowen & Co. on February 22, 2023. The analyst firm set a price target for $2.00 expecting APPH to rise to within 12 months (a possible 120.09% upside). 3 analyst firms have reported ratings in the last year.

科文有限公司於 2023 年 2 月 22 日報導了亞太醫藥(納斯達克股票代碼:APPH)的最新目標價格。該分析師公司設定了 2.00 美元的價格目標,預計 APPH 將在 12 個月內上漲(可能是 120.09% 的上漲)。3 家分析師公司在去年報告了評級。

What is the most recent analyst rating for AppHarvest (APPH)?

亞太藥(APPH)的最新分析師評級為何?

The latest analyst rating for AppHarvest (NASDAQ: APPH) was provided by Cowen & Co., and AppHarvest maintained their outperform rating.

亞太醫藥(納斯達克股份代號:APPH)的最新分析師評級由 Cowen & Co. 提供,而亞太藥維持其「表現優越」評級。

When is the next analyst rating going to be posted or updated for AppHarvest (APPH)?

亞太醫藥 (APPH) 的下一個分析師評級何時會公佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AppHarvest, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AppHarvest was filed on February 22, 2023 so you should expect the next rating to be made available sometime around February 22, 2024.

分析師在進行了廣泛的研究後抵達股票評級,其中包括通過公共財務報表,與 APharVest 的高管和客戶交談以及聽取盈利電話會議。大多數分析師每三個月這樣做一次,因此您應該每年每家公司獲得 4 個評級。APharVest 的最後一個評分於 2023 年 2 月 22 日提交,因此您應該期望下一個評級將在 2024 年 2 月 22 日左右的某個時間提供。

Is the Analyst Rating AppHarvest (APPH) correct?

分析師評級亞太藥業(APPH)是否正確?

While ratings are subjective and will change, the latest AppHarvest (APPH) rating was a maintained with a price target of $9.00 to $2.00. The current price AppHarvest (APPH) is trading at is $0.91, which is out of the analyst's predicted range.

儘管評級是主觀的並且會發生變化,但最新的 APHE 評級維持在 9.00 美元至 2.00 美元的目標價格。當前價格亞太藥(APPH)的交易價格為 0.91 美元,超出了分析師的預測範圍。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論